Years active
—
Total patents
2
Frequent collaborator
Ulrike Gnad-Vogt
Domains
biotechpharmaceuticaloncologygene_editing
Patents
2
US 20160166668·Curevac AG
How an mRNA Vaccine Targets Prostate Cancer with Six Antigens
This patent describes an mRNA vaccine designed to treat prostate cancer by delivering genetic instructions for a specific combination of six prostate-related proteins, teaching the body to fight the cancer.
US 20160168227·Curevac AG
How an mRNA Vaccine for Lung Cancer Teaches the Immune System to Fight
This patent describes a specific mRNA vaccine designed to treat lung cancer by instructing the body's cells to produce six distinct tumor proteins, thereby training the immune system to recognize and attack cancer cells.
Patent monitoring
Get a weekly digest when new patents naming Karl-Josef Kallen are indexed.